Rohto Pharmaceutical Co.,Ltd. (RPHCF)
USD 20.09
(-24.56%)
USD 20.09
(-24.56%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 99.14 Billion JPY | 13823.97% |
| 2023 | 712.02 Million JPY | -4.63% |
| 2022 | 746.57 Million JPY | 18.64% |
| 2021 | 629.27 Million JPY | -10.15% |
| 2020 | 700.37 Million JPY | 12.74% |
| 2019 | 621.24 Million JPY | -5.24% |
| 2018 | 655.59 Million JPY | 15.69% |
| 2017 | 566.67 Million JPY | -6.75% |
| 2016 | 607.69 Million JPY | -99.09% |
| 2015 | 66.99 Billion JPY | 5.3% |
| 2014 | 63.62 Billion JPY | 11.87% |
| 2013 | 56.87 Billion JPY | 8.57% |
| 2012 | 52.38 Billion JPY | 7.87% |
| 2011 | 48.56 Billion JPY | 3.11% |
| 2010 | 47.09 Billion JPY | 4.73% |
| 2009 | 44.96 Billion JPY | -11.42% |
| 2008 | 50.76 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 643.47 Million JPY | 0.01% |
| 2024 FY | 99.14 Billion JPY | 13823.97% |
| 2024 Q1 | 643.38 Million JPY | -9.64% |
| 2024 Q4 | 99.14 Billion JPY | 14450.03% |
| 2024 Q3 | 681.38 Million JPY | 5.89% |
| 2023 Q4 | 712.02 Million JPY | -5.07% |
| 2023 Q1 | 723.95 Million JPY | -2.94% |
| 2023 Q2 | 667.98 Million JPY | -7.73% |
| 2023 Q3 | 750.03 Million JPY | 12.28% |
| 2023 FY | 712.02 Million JPY | -4.63% |
| 2022 Q3 | 761.38 Million JPY | -4.66% |
| 2022 Q2 | 798.57 Million JPY | 24.38% |
| 2022 Q1 | 642.04 Million JPY | 2.56% |
| 2022 FY | 746.57 Million JPY | 18.64% |
| 2022 Q4 | 745.85 Million JPY | -2.04% |
| 2021 Q1 | 67.22 Billion JPY | -11.09% |
| 2021 Q4 | 626.02 Million JPY | -99.07% |
| 2021 FY | 629.27 Million JPY | -10.15% |
| 2021 Q3 | 67.45 Billion JPY | -4.29% |
| 2021 Q2 | 70.47 Billion JPY | 4.84% |
| 2020 Q2 | 64.46 Billion JPY | 2.82% |
| 2020 FY | 700.37 Million JPY | 12.74% |
| 2020 Q4 | 75.61 Billion JPY | 13.71% |
| 2020 Q1 | 62.69 Billion JPY | -8.83% |
| 2020 Q3 | 66.49 Billion JPY | 3.15% |
| 2019 Q2 | 70.06 Billion JPY | 4.66% |
| 2019 FY | 621.24 Million JPY | -5.24% |
| 2019 Q1 | 66.94 Billion JPY | -3.99% |
| 2019 Q3 | 68.02 Billion JPY | -2.91% |
| 2019 Q4 | 68.76 Billion JPY | 1.09% |
| 2018 Q1 | 60.04 Billion JPY | -4.85% |
| 2018 FY | 655.59 Million JPY | 15.69% |
| 2018 Q2 | 64.1 Billion JPY | 6.76% |
| 2018 Q3 | 68.54 Billion JPY | 6.92% |
| 2018 Q4 | 69.72 Billion JPY | 1.73% |
| 2017 Q3 | 59.35 Billion JPY | 1.66% |
| 2017 FY | 566.67 Million JPY | -6.75% |
| 2017 Q4 | 63.1 Billion JPY | 6.32% |
| 2017 Q2 | 58.38 Billion JPY | -1.54% |
| 2017 Q1 | 59.3 Billion JPY | -13.18% |
| 2016 Q2 | 65.64 Billion JPY | 3.96% |
| 2016 Q3 | 67.29 Billion JPY | 2.5% |
| 2016 Q4 | 68.3 Billion JPY | 1.51% |
| 2016 FY | 607.69 Million JPY | -99.09% |
| 2016 Q1 | 63.15 Billion JPY | -5.74% |
| 2015 FY | 66.99 Billion JPY | 5.3% |
| 2015 Q4 | 66.99 Billion JPY | 2.02% |
| 2015 Q3 | 65.66 Billion JPY | 5.12% |
| 2015 Q2 | 62.46 Billion JPY | 9.49% |
| 2015 Q1 | 57.05 Billion JPY | -10.33% |
| 2014 Q3 | 62.66 Billion JPY | 13.08% |
| 2014 Q1 | 54.3 Billion JPY | -4.52% |
| 2014 Q4 | 63.62 Billion JPY | 1.53% |
| 2014 Q2 | 55.41 Billion JPY | 2.05% |
| 2014 FY | 63.62 Billion JPY | 11.87% |
| 2013 Q2 | 46.85 Billion JPY | 0.07% |
| 2013 FY | 56.87 Billion JPY | 8.57% |
| 2013 Q3 | 48.26 Billion JPY | 3.0% |
| 2013 Q1 | 46.82 Billion JPY | -10.61% |
| 2013 Q4 | 56.87 Billion JPY | 17.83% |
| 2012 FY | 52.38 Billion JPY | 7.87% |
| 2012 Q1 | 45.13 Billion JPY | -7.06% |
| 2012 Q2 | 47.23 Billion JPY | 4.66% |
| 2012 Q3 | 47.28 Billion JPY | 0.11% |
| 2012 Q4 | 52.38 Billion JPY | 10.78% |
| 2011 Q2 | 45.97 Billion JPY | 3.41% |
| 2011 FY | 48.56 Billion JPY | 3.11% |
| 2011 Q1 | 44.46 Billion JPY | -5.59% |
| 2011 Q3 | 45.4 Billion JPY | -1.25% |
| 2011 Q4 | 48.56 Billion JPY | 6.95% |
| 2010 Q2 | 44.37 Billion JPY | 0.0% |
| 2010 FY | 47.09 Billion JPY | 4.73% |
| 2010 Q4 | 47.09 Billion JPY | 6.22% |
| 2010 Q3 | 44.34 Billion JPY | -0.08% |
| 2009 Q4 | 44.96 Billion JPY | -8.56% |
| 2009 Q3 | 49.17 Billion JPY | 0.0% |
| 2009 FY | 44.96 Billion JPY | -11.42% |
| 2008 FY | 50.76 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | 816.02 Thousand USD | -12149357.121% |
| Bruush Oral Care Inc. | 2.59 Million USD | -3822001.975% |
| CCA Industries, Inc. | 1.69 Million USD | -5862935.766% |
| DSwiss, Inc. | 311.07 Thousand USD | -31870363.356% |
| EOS, Inc. | 1.56 Million USD | -6351841.999% |
| Greyson International, Inc. | 824.27 Thousand USD | -12027696.582% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 17.75 USD | -558546478773.239% |
| Infusion Brands International, Inc. | 29.09 Million USD | -340622.306% |
| Mandom Corporation | 132.5 Million USD | -74718.509% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | 64.28 Thousand USD | -154224901.556% |
| Oliveda International, Inc. | 3.78 Million USD | -2619042.284% |
| PacificHealth Laboratories, Inc. | 660.06 Thousand USD | -15020026.928% |
| Prosperous Future Holdings Limited | 22.67 Million USD | -437125.32% |
| PURE Bioscience, Inc. | 3.68 Million USD | -2692512.71% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | 9.18 Million USD | -1079183.146% |
| Sentient Brands Holdings Inc. | 2.11 Million USD | -4682364.115% |
| Sunset Capital Assets, Inc. | 830.25 Thousand USD | -11941036.228% |
| The Stephan Co. | 1.93 Million USD | -5123517.571% |
| Turner Valley Oil & Gas, Inc. | 329.77 Thousand USD | -30063428.163% |
| Winning Brands Corporation | 3.76 Million USD | -2631293.156% |
| Warpaint London PLC | 23.19 Million USD | -427251.827% |
| Zoono Group Limited | 1.83 Million USD | -5402889.841% |
| Zurvita Holdings, Inc. | 11.29 Million USD | -877654.87% |